Kirsti Gjellan

Member of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Jun 12, 2018 – Feb 21, 2025

Kirsti Gjellan reported 19 transactions between Jun 12, 2018 and Feb 21, 2025. The buy and sell totals below count only codes SACQ, SDIS.

Open-market buys (SACQ)
1.79M SEK
11 purchases on file priced rows only
Open-market sales (SDIS)
57.5K SEK
1 sale on file priced rows only
All reported transactions
19
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought Bio-Works Technologies AB shares worth 315,575 SEK between Feb 21, 2025 and Feb 24, 2025

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

4 insiders bought Bio-Works Technologies AB shares worth 315,575 SEK between Feb 21, 2025 and Feb 24, 2025
Date Insider Transaction Shares Price Value Filing
Feb 21, 2025 Kirsti Gjellan SACQ Acquisition 81,500 1.23 SEK 100,237 SEK FI filing ↗
Feb 21, 2025 Lone Poulsen Carlbom SACQ Acquisition 15,540 1.30 SEK 20,202 SEK FI filing ↗
Feb 24, 2025 Bengt Peter Nählstedt SACQ Acquisition 32,143 1.35 SEK 43,393 SEK FI filing ↗
Feb 24, 2025 Bengt Peter Nählstedt SACQ Acquisition 12,857 1.38 SEK 17,743 SEK FI filing ↗
Feb 24, 2025 Thomas Gür SACQ Acquisition 100,000 1.34 SEK 134,000 SEK FI filing ↗

Total of the rows above: 315,575 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

6 insiders bought Bio-Works Technologies AB shares worth 845,640 SEK between Feb 19, 2024 and Mar 8, 2024

Cluster buying

6 different insiders made 13 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

6 insiders bought Bio-Works Technologies AB shares worth 845,640 SEK between Feb 19, 2024 and Mar 8, 2024
Date Insider Transaction Shares Price Value Filing
Feb 19, 2024 Jonathan Tyler Royce SACQ Acquisition 1,899 5.08 SEK 9,647 SEK FI filing ↗
Feb 19, 2024 Jonathan Tyler Royce SACQ Acquisition 4,298 5.10 SEK 21,920 SEK FI filing ↗
Feb 19, 2024 Jonathan Tyler Royce SACQ Acquisition 146 5.14 SEK 750 SEK FI filing ↗
Feb 19, 2024 Jonathan Tyler Royce SACQ Acquisition 374 5.24 SEK 1,960 SEK FI filing ↗
Feb 19, 2024 Gustaf Peter Reinhold von Ehrenheim SACQ Acquisition 50,000 4.99 SEK 249,500 SEK FI filing ↗
Feb 19, 2024 Gustaf Peter Reinhold von Ehrenheim SACQ Acquisition 50,000 5.20 SEK 260,000 SEK FI filing ↗
Feb 21, 2024 Kirsti Gjellan SACQ Acquisition 22,000 4.53 SEK 99,603 SEK FI filing ↗
Feb 27, 2024 Bengt Peter Nählstedt SACQ Acquisition 1,700 4.20 SEK 7,140 SEK FI filing ↗
Feb 27, 2024 Bengt Peter Nählstedt SACQ Acquisition 5,000 4.30 SEK 21,500 SEK FI filing ↗
Feb 27, 2024 Johan Sedihn SACQ Acquisition 10,000 4.20 SEK 42,000 SEK FI filing ↗
Feb 29, 2024 Bengt Peter Nählstedt SACQ Acquisition 3,300 4.28 SEK 14,124 SEK FI filing ↗
Mar 1, 2024 Karsten Erik Andreas Fjärstedt SACQ Acquisition 14,000 4.15 SEK 58,100 SEK FI filing ↗
Mar 8, 2024 Karsten Erik Andreas Fjärstedt SACQ Acquisition 12,400 4.79 SEK 59,396 SEK FI filing ↗

Total of the rows above: 845,640 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

5 insiders bought Xbrane Biopharma AB shares worth 780,834 SEK between Jun 1, 2023 and Jun 21, 2023

Cluster buying

5 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

5 insiders bought Xbrane Biopharma AB shares worth 780,834 SEK between Jun 1, 2023 and Jun 21, 2023
Date Insider Transaction Shares Price Value Filing
Jun 1, 2023 Anette Lindqvist SACQ Acquisition 3,000 78.80 SEK 236,400 SEK FI filing ↗
Jun 13, 2023 Anders Olof Wallström SACQ Acquisition 1,869 80.09 SEK 149,688 SEK FI filing ↗
Jun 13, 2023 Nina Ivers SACQ Acquisition 621 80.00 SEK 49,680 SEK FI filing ↗
Jun 15, 2023 Karl Martin Erik Åmark SACQ Acquisition 1,869 80.09 SEK 149,688 SEK FI filing ↗
Jun 21, 2023 Kirsti Gjellan SACQ Acquisition 2,500 78.15 SEK 195,379 SEK FI filing ↗

Total of the rows above: 780,834 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 19 most recent rows are grouped into 19 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Bio-Works Technologies AB SACQ Acquisition 81,500 shares 100.2K SEK at 1.23 SEK FI filing ↗
  2. Bio-Works Technologies AB SACQ Acquisition 18,674 shares 15.4K SEK at 0.83 SEK FI filing ↗
  3. Bio-Works Technologies AB SACQ Acquisition 99,000 shares 99.0K SEK at 1.00 SEK FI filing ↗
  4. Bio-Works Technologies AB SACQ Acquisition 99,000 shares 99.0K SEK at 1.00 SEK FI filing ↗
  5. Bio-Works Technologies AB SACQ Acquisition 6,388 shares 12.8K SEK at 2.00 SEK FI filing ↗
  6. Bio-Works Technologies AB SDIS Disposal 28,456 shares 57.5K SEK at 2.02 SEK FI filing ↗
  7. Bio-Works Technologies AB SACQ Acquisition 30,612 shares 63.4K SEK at 2.07 SEK FI filing ↗
  8. Xbrane Biopharma AB SSUB Subscriptionnot a buy/sell decisionreported at zero 22,500 shares 0 SEK at 0.00 SEK FI filing ↗
  9. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 125,000 shares 28.8K SEK at 0.23 SEK FI filing ↗
  10. Xbrane Biopharma AB SSUB Subscriptionnot a buy/sell decision 2,500 shares 28.8K SEK at 11.50 SEK FI filing ↗
  11. Bio-Works Technologies AB SACQ Acquisition 22,000 shares 99.6K SEK at 4.53 SEK FI filing ↗
  12. Xbrane Biopharma AB SACQ Acquisition 2,500 shares 195.4K SEK at 78.15 SEK FI filing ↗
  13. Bio-Works Technologies AB SACQ Acquisition 40,000 shares 1.01M SEK at 25.32 SEK FI filing ↗
  14. Bio-Works Technologies AB SSUB Subscriptionnot a buy/sell decision 15,600 shares 181.3K SEK at 11.62 SEK FI filing ↗
  15. Bio-Works Technologies AB SSUB Subscriptionnot a buy/sell decision 15,600 shares 181.3K SEK at 11.62 SEK FI filing ↗
  16. Bio-Works Technologies AB SSUB Subscriptionnot a buy/sell decision 2,856 shares 18.0K SEK at 6.30 SEK FI filing ↗
  17. Bio-Works Technologies AB SALL Allotmentnot a buy/sell decision 10,000 shares 1.4K SEK at 0.14 SEK FI filing ↗
  18. Bio-Works Technologies AB SACQ Acquisition 15,000 shares 13.2K SEK at 0.88 SEK FI filing ↗
  19. Bio-Works Technologies AB SACQ Acquisition 10,000 shares 80.3K SEK at 8.03 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Xbrane Biopharma AB SE0007789409 Xbrane Biopharma AB 127,500 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Kirsti Gjellan reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.